Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.
de Almeida Baptista MV, da Silva LT, Samer S, Oshiro TM, Shytaj IL, Giron LB, Pena NM, Cruz N, Gosuen GC, Ferreira PRA, Cunha-Neto E, Galinskas J, Dias D, Sucupira MCA, de Almeida-Neto C, Salomão R, da Silva Duarte AJ, Janini LM, Hunter JR, Savarino A, Juliano MA, Diaz RS. de Almeida Baptista MV, et al. Among authors: oshiro tm. AIDS Res Ther. 2022 Jan 12;19(1):2. doi: 10.1186/s12981-021-00426-z. AIDS Res Ther. 2022. PMID: 35022035 Free PMC article. Clinical Trial.
Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19.
Ortega MM, da Silva LT, Candido ÉD, Zheng Y, Tiyo BT, Ferreira AEF, Corrêa-Silva S, Scagion GP, Leal FB, Chalup VN, Valério CA, Schmitz GJH, Ceneviva C, Corá AP, de Almeida A, Durigon EL, Oliveira DBL, Palmeira P, da Silva Duarte AJ, Carneiro-Sampaio M, Oshiro TM. Ortega MM, et al. Among authors: oshiro tm. Sci Rep. 2022 Jun 16;12(1):10125. doi: 10.1038/s41598-022-14283-x. Sci Rep. 2022. PMID: 35710573 Free PMC article.
Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.
Palma ML, Duangkhae P, Douradinha B, Viana IFT, Rigato PO, Dhalia R, Mailliard RB, Barratt-Boyes SM, Nascimento EJM, Oshiro TM, da Silva Duarte AJ, Marques ETA. Palma ML, et al. Among authors: oshiro tm. Gene Ther. 2017 Jun;24(6):342-352. doi: 10.1038/gt.2017.25. Epub 2017 Apr 17. Gene Ther. 2017. PMID: 28414303
33 results